Anna-Luisa Luger

7PUBLICATIONS
18CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsPredictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 26, 2026
Tumor-associated epilepsy and high expression of xCT shape the proteome of IDH-wildtype glioblastoma.

Iris Divé, Jasmin A Schäfer, Katharina J Weber

|Aug 26, 2024
Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1.

Sven König, Florian Strassheimer, Nadja I Brandner

|Aug 02, 2023
Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.

Bernhard Neumann, Julia Onken, Nicole König

|Jul 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.

Anna-Luisa Luger, Sven König, Patrick Felix Samp

|Oct 23, 2020
Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer.

Hans Urban, Gabriele D Maurer, Anna-Luisa Luger

|Aug 07, 2020
Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death.

Anna-Luisa Luger, Nadja I Lorenz, Hans Urban

Pageof 2

Frequent Collaborators

5 joint publications

Michael W Ronellenfitsch

1 joint publications

Martin A Schaller-Paule

1 joint publications

Peter Baumgarten

1 joint publications

Katja Dettmer